Kavar Capital Partners Group, Llc
Source: SEC Form 13F · as of Mar 2026Kavar Capital Partners Group, Llc holds 13 biotech & pharma companies tracked by BioSniper, totaling $38.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$38.8M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 43,689 | $10.7M |
| ABBVAbbVie Inc. | 46,963 | $10.2M |
| ABTABBOTT LABORATORIES | 40,073 | $4.1M |
| LLYELI LILLY & Co | 3,904 | $3.6M |
| PMPhilip Morris International Inc | 18,268 | $3.0M |
| DGXQuest Diagnostics Incorporated | 12,358 | $2.4M |
| MRKMerck & Co., Inc. | 15,864 | $1.9M |
| PFEPFIZER INC | 26,737 | $751K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,237 | $605K |
| MCKMcKesson Corporation | 660 | $571K |
| AMGNAMGEN INC | 1,063 | $374K |
| BMYBRISTOL MYERS SQUIBB CO | 4,802 | $291K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 4,597 | $254K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.